oxybutynin has been researched along with Diarrhea in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Extended-release formulations of oxybutynin at 10 mg/d or tolterodine at 4 mg/d were given for 12 weeks to women with 21 to 60 urge urinary incontinence (UUI) episodes per week and an average of 10 or more voids per 24 hours." | 5.10 | Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. ( Appell, RA; Diokno, AC; Dmochowski, RR; Gburek, BM; Kell, SH; Klimberg, IW; Sand, PK, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diokno, AC | 1 |
| Appell, RA | 1 |
| Sand, PK | 1 |
| Dmochowski, RR | 1 |
| Gburek, BM | 1 |
| Klimberg, IW | 1 |
| Kell, SH | 1 |
| Chideckel, EW | 1 |
| Coyle, VM | 1 |
| Lungulescu, D | 1 |
| Toganel, C | 1 |
| Niculescu, A | 1 |
| Pop, S | 1 |
| Ciuleanu, T | 1 |
| Cebotaru, C | 1 |
| Devane, J | 1 |
| Martin, M | 1 |
| Wilson, RH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of the Efficacy and Tolerability of DITROPAN XL and DETROL LA in the Treatment of Overactive Bladder[NCT00293839] | Phase 3 | 790 participants (Actual) | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for oxybutynin and Diarrhea
| Article | Year |
|---|---|
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
Topics: Administration, Oral; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations | 2003 |
A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.
Topics: Adult; Aged; Antidiarrheals; Delayed-Action Preparations; Diarrhea; Double-Blind Method; Female; Hum | 2013 |
1 other study available for oxybutynin and Diarrhea
| Article | Year |
|---|---|
Oxybutynin for diabetic complications.
Topics: Diabetes Complications; Diarrhea; Female; Humans; Male; Mandelic Acids; Middle Aged; Parasympatholyt | 1990 |